Меню
Идёт набор NCT07656324

Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue

— Наблюдательное Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: No Interventions.
Кому может быть актуально
Состояния в реестре: Cancer. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Китай
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Обзор

This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.

Подробное описание

This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis. Using patient-completed questionnaires, combined with outpatient visit records and telephone follow-up, this study will explore the following aspects:

Assess the incidence and severity of cancer-related fatigue in patients with malignant tumors.

Analyze the influencing factors of cancer-related fatigue, including tumor type, treatment regimen, disease stage, efficacy of anti-tumor therapy, adverse events associated with anti-tumor therapy, and concomitant medications.

Evaluate the impact of cancer-related fatigue on anti-tumor treatment and prognosis.

Assess the multidimensional state and severity of cancer-related fatigue in patients with malignant tumors using the Brief Fatigue Inventory - Cancer (BFI-C) and the Multidimensional Fatigue Symptom Inventory - Short Form (MFSI-SF).

By collecting patients' medical information, including imaging and laboratory results, as well as outpatient and telephone follow-up records, this study will explore the following aspects:

Evaluate the impact of different degrees of cancer-related fatigue on the prognosis of patients with malignant tumors.

Explore the impact of the efficacy of anti-tumor therapy on the multidimensional state and severity of cancer-related fatigue in patients.

Вмешательства

  • Другое No Interventions
    No Interventions

Первичные конечные точки

  • The incidence of cancer-related fatigue (CRF) in tumor patients. [Срок оценки: Baseline]
Вторичные конечные точки (5)
  • The severity grading of cancer-related fatigue (CRF) in tumor patients across different tumor types and multiple treatment settings. [Срок оценки: Baseline]
  • The correlation between treatment regimen and the incidence of cancer-related fatigue (CRF). [Срок оценки: Baseline]
  • The incidence of anti-tumor treatment delays, dose reductions, or regimen modifications due to cancer-related fatigue (CRF). [Срок оценки: Baseline]
  • Progression-free survival (PFS) and overall survival (OS) in patients with different grades of cancer-related fatigue (CRF) undergoing anti-tumor therapy. [Срок оценки: Baseline]
  • To assess the state and severity of cancer-related fatigue (CRF) in patients with malignant tumors using the Brief Fatigue Inventory - Cancer (BFI-C) and the Multidimensional Fatigue Symptom Inventory - Short Form (MFSI-SF). [Срок оценки: Baseline]

Критерии участия

Критерии включения

  • Male or female, aged 18 years or older.
  • Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form.
  • Malignant tumor confirmed histologically or cytologically.

Критерии исключения

  • Pregnant or breastfeeding women.
  • Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study.
  • Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma).
  • Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses.
  • Patients with severe organic disease or major organ failure, such as decompensated heart, lung, liver, or kidney failure.
  • Patients with other conditions that, in the investigator's opinion, make them unsuitable for participation in this study.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Когортное

Центры проведения

Китай · 1 центр
  • Fudan University Shanghai Cancer Center — Шанхай

Идентификаторы

NCT: NCT07656324 · CRF-01 · CRF-01

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗